Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-01

Clinical Trial Update: New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients

View source ↗

Summary

This clinical trial evaluating new urine and blood biomarkers for acute kidney injury in liver transplant patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Colorado, Denver | Conditions: Renal Insufficiency, Acute | Status: WITHDRAWN